Penanganan Proctosigmoiditis tanpa Terapi Rektal: Sebuah Laporan Kasus Ulcerative Colitis pada Pasien Pria Usia 38 Tahun

Sari Mahmudah, Cecilia Brata

Sari


ABSTRACT

 

Ulcerative colitis (UC) is a chronic immune-mediated inflammatory bowel condition that is often associated with rectal inflammation but often extends proximally to involve additional areas of the colon. The initial presentation of new UC is characterized by symptoms of an inflamed rectum, namely bleeding, urgency and tenesmus (pressure). The choice of treatment depends on the severity of the disease, location and course of the disease. For proctosigmoiditis, topical therapy with 5-aminosalicylic acid (5-ASA) compounds is used. For more extensive or severe disease, oral 5-ASA compounds and corticosteroids should be used to induce remission In this case, the patient had complained of chronic diarrhea for 1 year and only had diarrhea medication. Recently the patient was diagnosed with mild active UC type proctosigmoiditis and the therapy received by the patient was Sulfasalazine 500 mg 3x1 tab without topical 5-ASA. The patient was hospitalized for 7 days and was discharged from the hospital with improved clinical condition.

 

Kata Kunci: Ulcerative Colitis, Proctosigmoiditis, Case Report.

 

 

ABSTRAK

 

Ulcerative colitis (UC) merupakan kondisi peradangan usus besar kronis yang dimediasi imun yang sering dikaitkan dengan peradangan rektum tetapi sering meluas ke proksimal hingga melibatkan area tambahan di kolon. Presentasi awal UC baru ditandai dengan gejala rektum yang meradang, yaitu pendarahan, urgensi dan tenesmus (rasa tertekan).Pilihan pengobatan tergantung pada tingkat keparahan penyakit, lokalisasi dan perjalanan penyakit. Untuk proctosigmoiditis, digunakan terapi topikal dengan senyawa asam 5-aminosalisilat (5-ASA). Untuk penyakit yang lebih luas atau parah harus diobati dengan senyawa 5-ASA oral dan kortikosteroid untuk menginduksi remisi. Pada kasus ini pasien telah mengeluhkan diare kronis selama 1 tahun hanya diberikan obat diare. Belakangan terakhir pasien didiagnosa UC aktif derajat ringan tipe proctosigmoiditis dan terapi yang didapatkan pasien adalah Sulfasalazine 500 mg 3x1 tab tanpa pemberian 5-ASA topikal. Pasien menjalani rawat inap selama 7 hari dan keluar rumah sakit dengan kondisi klinis yang membaik.

 

Kata Kunci: Kolitis UlseratifProctosigmoiditis, Laporan Kasus.


Teks Lengkap:

Download Artikel

Referensi


Acg Clinical Guideline (2019): Ulcerative Colitis In Adult. The American Journal Of Gastroenterology. Doi: 10.14309/Ajg.0000000000000152

Ammatullah A Dan Miro S. (2021). Pankolitis Akibat Kolitis Ulseratif. Heme Vol Iii No 2, July.

Bonovas S Et Al. (2021). Ecco Guidelines On Therapeutics In Ulcerative Colitis: Medical Treatment. 2021

Bressler B, Marshall Jk, Bernstein Cn, Bitton A, Jones J, Leontiadis Gi, Panaccione R, Steinhart Ah, Tse F, Feagen B; Toronto Ulcerative Colitis Consensus Group. (2015). “Clinical Practice Guidelines For The Medical Management Of Nonhospitalized Ulcerative Colitis: The Toronto Consensus.” Gastroenterology 148, No.5 1035 58.E3.10.1053/J.Gastro.2015.03.001

Christophi Gp, Arvind R, Matthew Ac. (2016). Rectal Budesonide And Mesalamine Formulations In Active Ulcerative Proctosigmoiditis: Efficacy, Tolerance, And Treatment Approach. May

Ford Et Al. (2012). Efficacy Of Oral Vs Topical, Or Combined Oral And Topical 5-Aminosalicylates, In Ulcerative Colitis: Systematic Review And Meta-Analysis. Am J Gastroenterol 107:167-176: Doi:10.1038/Ajg.2011.410;Published Online 22 November 2011

Furian Rs., Et Al. (2017). Ulcerative Proctosigmoiditis Exacerbated By Recurrent Clostridium Colitis: Case Report. Journal Of Gastroenterology, Hepatology And Endoscopy. 2(5):1-3

Gajendran M, Loganathan P, Jimenez G, Catinella Ap, Ng N, Umapathy C Et Al. (2019). A Comprehensive Review And Update On Ulcerative Colitis., Disease A Month. 65 (12).

Gesce Kb, Vermeire S. (2018). Differential Diagnosis Of Inflammatory Bowel Disease: Imitations And Complications. Lancet Gastroenterol Hepatol 3: 644-653.

Kaplan Gg, Ng Sc. (2017). Understanding And Preventing The Global Increase Of Inflammatory Bowel Disease. Gastroenterology.152(2):313-321.E2.

Konsensus Nasional (2022). Penatalaksanaan Inflammatory Bowel Disease (Ibd) Di Indonesia.

Kornbluth A, Sachar Db. (2010). Ulcerative Colitis Practice Guidelines In Adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 105:501–523. Doi: 10.1038/Ajg.2009.727. Quiz 524.

Lamb Ca, Kennedy Na, Raine T, Dkk. (2019). Pedoman Konsensus British Society Of Gastroenterology Tentang Penanganan Penyakit Radang Usus Pada Orang Dewasa. Gut 68:S1–106.

Marshall Jk, Irvine Ej. (1995). Rectal Aminosalicylate Therapy For Distal Ulcerative Colitis: A Meta-Analysis. Aliment Pharmacol Ther. 9:293–300. Doi: 10.1111/J.13652036.1995.Tb00384.X

Ordás I, Eckmann L, Talamini M, Baumgart Dc, Sandborn Wj.(2012). Ulcerative Colitis. Lancet. 380(9853):1606-1619.

Penyakit Radang Usus (Ibd). (2014) Situs Web Pusat Pengendalian Dan Pencegahan Penyakit. Www.Cdc.Gov/Ibd Tautan Eksternal.

Turner D Et Al (2021). Stride-Ii: An Update On The Selecting Therapeutic Targets In Inflammatory Bowel Disease (Stride) Initiative Of The International Organization For The Study Of Ibd (Ioibd): Determining Therapeutic Goals For Treat-To-Target Strategies In Ibd.

Watanabe M, Nishino H, Sameshima Y, Ota A, Nakamura S, Hibi T. (2013). Randomised Clinical Trial: Evaluation Of The Efficacy Of Mesalazine (Mesalamine) Suppositories In Patients With Ulcerative Colitis And Active Rectal Inflammation – A Placebo-Controlled Study. Aliment Pharmacol Ther.38:264–273. Doi: 10.1111/Apt.12362.




DOI: https://doi.org/10.33024/mahesa.v6i2.20667

Refbacks

  • Saat ini tidak ada refbacks.


Publisher: Universitas Malahayati Lampung


Creative Commons License
Semua artikel dapat digunakan dibawah lisensi Creative Commons Attribution-ShareAlike 4.0 International License